Dixon Hughes Goodman Wealth Advisors’s GreenLight Biosciences Holdings, PBC Common Stock GRNA Stock Holding History

Dixon Hughes Goodman Wealth Advisors’s Portfolio GRNA Stock Details GRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$1K	Hold	150	–	–	﹤0.01%	866
2021 Q4	$1K	Buy	+150	New	+$1.49K	﹤0.01%	807

Other funds holding GRNA

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

VK Services Menlo Park, California $543K AUM 174.84% 1-Year Est. Return

CGC

Continental Grain Company New York $366M AUM 0.18% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

TCM

Tao Capital Management San Francisco, California $119M AUM 87.46% 1-Year Est. Return

BOTOTLSJU

Board of Trustees of The Leland Stanford Junior University Redwood City, California $849M AUM 55.45% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

OCMH

Oxbow Capital Management (HK) Hong Kong $371M AUM 383.45% 1-Year Est. Return

Dixon Hughes Goodman Wealth Advisors's GRNA Position: Q1 2022 in Review

Dixon Hughes Goodman Wealth Advisors held its GreenLight Biosciences Holdings, PBC Common Stock (GRNA) position steady in Q1 2022 at 150 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #866.

Dixon Hughes Goodman Wealth Advisors first reported a position in GRNA in Q4 2021 and has held it in 2 quarters since. 39 funds tracked by Wall St. Rank hold GRNA as of Q1 2022.

Dixon Hughes Goodman Wealth Advisors held 150 shares of GreenLight Biosciences Holdings, PBC Common Stock worth $1K as of Q1 2022.
Dixon Hughes Goodman Wealth Advisors left its GreenLight Biosciences Holdings, PBC Common Stock share count unchanged in Q1 2022.
GreenLight Biosciences Holdings, PBC Common Stock made up ﹤0.01% of Dixon Hughes Goodman Wealth Advisors's portfolio in Q1 2022, its #866 holding.
Dixon Hughes Goodman Wealth Advisors first reported a position in GreenLight Biosciences Holdings, PBC Common Stock in Q4 2021 and has held it in 2 quarters since.
39 funds tracked by Wall St. Rank held GreenLight Biosciences Holdings, PBC Common Stock as of Q1 2022.

Based on Dixon Hughes Goodman Wealth Advisors's 13F filing for Q1 2022, filed 4 Apr 2022.